Infliximab does not interfere with insulin secretion, insulin resistance and production of GAD and islet cell antibodies in patients with Crohn's disease
- 1 July 2002
- journal article
- clinical trial
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 4 (4) , 276-277
- https://doi.org/10.1046/j.1463-1326.2002.00210.x
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Dual role of interferon-γ signalling pathway in sensitivity of pancreatic beta cells to immune destructionDiabetologia, 2001
- Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitisThe Lancet, 1992
- Immunology and diabetes workshop: Report on the third international (Stage 3) workshop on the standardisation of cytoplasmic islet cell antibodiesDiabetologia, 1988